Stay updated on Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, while the previous version v2.16.4 has been removed. Additionally, a note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    0.7%
    Check dated 2025-07-05T04:18:30.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025.
    Difference
    0.6%
    Check dated 2025-06-20T19:44:18.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-13T16:19:17.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page has undergone a significant update, with the removal of a citation regarding the mutational landscape of metastatic cancer and its replacement with a new version number, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-06-06T10:05:02.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.
    Difference
    0.8%
    Check dated 2025-05-30T04:51:43.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The page has been updated to include a new version number and a reference to a bladder cancer article, while an erratum and the previous version number have been removed.
    Difference
    2%
    Check dated 2025-05-23T02:13:01.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Durvalumab Immuno-oncology Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Durvalumab Immuno-oncology Clinical Trial page.